XML 22 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
As reported
Common Stock
Common Stock
As reported
Common Stock
Revision of Prior Period, Adjustment
Additional Paid-In Capital
Additional Paid-In Capital
As reported
Additional Paid-In Capital
Revision of Prior Period, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
As reported
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
As reported
Non-Controlling Interest
Non-Controlling Interest
As reported
Treasury Stock
Treasury Stock
As reported
Treasury Stock
Revision of Prior Period, Adjustment
Beginning balance (in shares) at Dec. 31, 2018       128,285,514 938,557 127,346,957                     0 0 0
Beginning balance at Dec. 31, 2018 $ 898,026   $ 898,026 $ 13 $ 9 $ 4 $ 950,770 $ 950,774 $ (4) $ (1,309) $ (1,309) $ (68,377)   $ (68,377) $ 16,929 $ 16,929 $ 0 $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Share-based compensation 1,822           1,822                        
Contributions related to acquisitions 200           200                        
Accounting Standards Update [Extensible Enumeration]   us-gaap:AccountingStandardsUpdate201104Member                                  
Other comprehensive income (loss) [1] (16)                 (16)                  
Distribution to non-controlling interest holder (4,862)                           (4,862)        
Net income attributable to non-controlling interest 4,400                           4,400        
Net (loss) income 5,349                     5,349              
Ending balance (in shares) at Dec. 31, 2019       128,285,514                         0    
Ending balance at Dec. 31, 2019 904,919 $ (405)   $ 13     952,792     (1,325)   (63,028) $ (405)   16,467   $ 0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Share-based compensation 1,936           1,936                        
Other comprehensive income (loss) [1] (582)                 (582)                  
Distribution to non-controlling interest holder (4,453)                           (4,453)        
Net income attributable to non-controlling interest 5,073                           5,073        
Net (loss) income (5,371)                     (5,371)              
Ending balance (in shares) at Dec. 31, 2020       128,285,514                         0    
Ending balance at Dec. 31, 2020 901,117     $ 13     954,728     (1,907)   (68,804)     17,087   $ 0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net proceeds from FAII in Business Combination (in shares)       25,512,254                              
Net proceeds from FAII in Business Combination 210,105     $ 3     210,102                        
Shares issued through PIPE investment (in shares)       30,000,000                              
Shares issued through PIPE investment 300,000     $ 3     299,997                        
Shares issued to Wilco Holdco Series A Preferred stockholders (in shares)       12,845,282                              
Shares issued to Wilco Holdco Series A Preferred stockholders 128,453     $ 1     128,452                        
Warrant liability recognized upon the closing of the Business Combination (26,936)           (26,936)                        
Contingent common shares liability recognized upon the closing of the Business Combination (220,500)           (220,500)                        
Share-based compensation 5,754           5,754                        
Other comprehensive income (loss) [1] 1,935                 1,935                  
Distribution to non-controlling interest holder (6,298)                           (6,298)        
Net income attributable to non-controlling interest (3,700)                           (3,700)        
Net (loss) income $ (778,328)                     (778,328)              
Vesting of restricted shares related to converted ICUs (in shares)       691,232                              
Issuance of common stock upon vesting or exercise of equity awards (in shares)       105,473                              
Tax withholdings related to net share settlement of restricted stock awards (in shares) 30,000.00     (29,791)                         29,791    
Tax withholdings related to net share settlement of restricted stock awards $ (95)                               $ (95)    
Ending balance (in shares) at Dec. 31, 2021       197,409,964                         29,791    
Ending balance at Dec. 31, 2021 $ 511,507     $ 20     $ 1,351,597     $ 28   $ (847,132)     $ 7,089   $ (95)    
[1] Other comprehensive income (loss) related to unrealized gain (loss) on interest rate swap